Previous close | 4.2700 |
Open | 4.2000 |
Bid | 4.2100 x 200 |
Ask | 4.2700 x 100 |
Day's range | 4.1100 - 4.2550 |
52-week range | 4.0300 - 9.0700 |
Volume | |
Avg. volume | 3,196,262 |
Market cap | 869.685M |
Beta (5Y monthly) | 1.93 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to...